Review: taking Citalopram hydrobromide and Omeprazole together


Summary

Drug interactions are reported among people who take Citalopram hydrobromide and Omeprazole together. This review analyzes the effectiveness and drug interactions between Citalopram hydrobromide and Omeprazole. It is created by eHealthMe based on reports of 6,966 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Citalopram hydrobromide and Omeprazole >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Citalopram Hydrobromide

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. (latest outcomes from Citalopram hydrobromide 24,725 users)

Omeprazole

Omeprazole has active ingredients of omeprazole. It is often used in gastrooesophageal reflux disease. (latest outcomes from Omeprazole 112,454 users)

On Aug, 27, 2016

6,966 people who take Citalopram Hydrobromide, Omeprazole are studied.


Number of reports submitted per year:

Citalopram hydrobromide and Omeprazole drug interactions.

Drug effectiveness over time:

Citalopram Hydrobromide:
  • < 1 month: 33.0% - (3 of 9 people)
  • 1 - 6 months: 28.0% - (11 of 39 people)
  • 6 - 12 months: 70.0% - (14 of 20 people)
  • 1 - 2 years: 42.0% - (14 of 33 people)
  • 2 - 5 years: 47.0% - (22 of 46 people)
  • 5 - 10 years: 42.0% - (11 of 26 people)
  • 10+ years: 55.0% - (10 of 18 people)
  • not specified: 0.0% - (0 of 4 people)
Omeprazole:
  • < 1 month: 20.0% - (4 of 20 people)
  • 1 - 6 months: 50.0% - (11 of 22 people)
  • 6 - 12 months: 38.0% - (7 of 18 people)
  • 1 - 2 years: 71.0% - (23 of 32 people)
  • 2 - 5 years: 75.0% - (36 of 48 people)
  • 5 - 10 years: 77.0% - (34 of 44 people)
  • 10+ years: 78.0% - (15 of 19 people)
  • not specified: 25.0% - (1 of 4 people)

Drug effectiveness by gender:

Citalopram Hydrobromide:
  • female: 42.0% - (59 of 138 people)
  • male: 45.0% - (26 of 57 people)
Omeprazole:
  • female: 57.0% - (84 of 147 people)
  • male: 78.0% - (47 of 60 people)

Drug effectiveness by age:

Citalopram Hydrobromide:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 25.0% - (1 of 4 people)
  • 20-29: 50.0% - (7 of 14 people)
  • 30-39: 46.0% - (14 of 30 people)
  • 40-49: 40.0% - (18 of 44 people)
  • 50-59: 46.0% - (21 of 45 people)
  • 60+: 41.0% - (24 of 58 people)
Omeprazole:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 5 people)
  • 20-29: 71.0% - (10 of 14 people)
  • 30-39: 64.0% - (20 of 31 people)
  • 40-49: 66.0% - (34 of 51 people)
  • 50-59: 71.0% - (33 of 46 people)
  • 60+: 56.0% - (34 of 60 people)

Most common drug interactions over time *:

< 1 month:
  • vomiting
  • confusional state
  • hyponatraemia
  • diarrhoea
  • hallucination
  • rheumatoid arthritis
  • serotonin syndrome
  • headache
  • fatigue
  • back pain
1 - 6 months:
  • syncope
  • cough
  • malaise
  • chronic obstructive pulmonary disease
  • depression
  • back pain
  • loss of consciousness
  • cardiac failure congestive
  • coronary arterial stent insertion
  • heart rate irregular
6 - 12 months:
  • pain
  • hip fracture
  • osteopenia
  • rib fracture
  • stress fracture
  • renal failure acute
  • bone density decreased
  • anxiety
  • dyskinesia
  • pneumonia fungal
1 - 2 years:
  • depression
  • nausea
  • depressed level of consciousness
  • fall
  • renal failure acute
  • serotonin syndrome
  • vomiting
  • arthritis
  • tubulointerstitial nephritis
  • dehydration
2 - 5 years:
  • diarrhoea
  • depression
  • abdominal pain
  • muscle spasms
  • anxiety
  • impaired healing
  • vomiting
  • chest pain
  • colonic polyp
  • haemorrhoids
5 - 10 years:
  • confusion
  • hyponatraemia
  • syncope
  • depression
  • dehydration
  • fatigue
  • nightmare
  • vertigo
  • aggression
  • anger
10+ years:
  • osteoporosis
  • foot fracture
  • pain in extremity
  • pain
  • mental disorder
  • osteopenia
  • osteoarthritis
  • depression
  • fall
  • fatigue
not specified:
  • pain
  • nausea
  • anxiety
  • fall
  • dyspnoea
  • fatigue
  • depression
  • diarrhoea
  • vomiting
  • arthralgia

Most common drug interactions by gender *:

female:
  • pain
  • nausea
  • anxiety
  • fall
  • depression
  • diarrhoea
  • fatigue
  • dyspnoea
  • vomiting
  • back pain
male:
  • pain
  • anxiety
  • dyspnoea
  • pneumonia
  • nausea
  • fatigue
  • depression
  • asthenia
  • arthralgia
  • fall

Most common drug interactions by age *:

0-1:
  • premature baby
  • cognitive disorder
  • drug withdrawal syndrome neonatal
  • gait disturbance
  • hypocalcaemia
  • neonatal respiratory distress syndrome
  • pneumothorax
  • urinary tract infection
  • abnormal behaviour
  • bradykinesia
2-9:
  • vomiting
  • depression
  • dysphemia
  • nausea
  • anaemia
  • emotional distress
  • eye disorder
  • hypertension
  • injury
  • pain
10-19:
  • anxiety
  • injury
  • pain
  • emotional distress
  • general physical health deterioration
  • cholecystitis chronic
  • chest pain
  • depression
  • cardiac arrest
  • headache
20-29:
  • vomiting
  • pain
  • abdominal pain
  • anxiety
  • deep vein thrombosis
  • depression
  • headache
  • nausea
  • pulmonary embolism
  • injury
30-39:
  • pain
  • depression
  • nausea
  • anxiety
  • asthenia
  • fatigue
  • fall
  • pulmonary embolism
  • vomiting
  • abdominal pain
40-49:
  • pain
  • anxiety
  • nausea
  • depression
  • diarrhoea
  • fatigue
  • arthralgia
  • headache
  • vomiting
  • back pain
50-59:
  • pain
  • anxiety
  • nausea
  • anaemia
  • arthralgia
  • fall
  • diarrhoea
  • fatigue
  • headache
  • dyspnoea
60+:
  • fall
  • dyspnoea
  • fatigue
  • pneumonia
  • pain
  • diarrhoea
  • nausea
  • anxiety
  • asthenia
  • confusional state

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Citalopram hydrobromide and Omeprazole?

Can you answer these questions?

More questions for: Citalopram hydrobromide, Omeprazole

You may be interested in these reviews

More reviews for: Citalopram hydrobromide, Omeprazole

On eHealthMe, Citalopram hydrobromide (citalopram hydrobromide) is often used to treat depression. Omeprazole (omeprazole) is often used to treat gastrooesophageal reflux disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.